Serina Therapeutics, Inc. Accounts Payable
Serina Therapeutics, Inc. (SER) had Accounts Payable of $1.70 million as of 2024-09-30, per its 10-Q filed 2024-11-12.
Financial Statements › Balance Sheet › Liabilities
us-gaap:AccountsPayableCurrentAndNoncurrent · last filed 2024-11-12
- 2024-09-30: Accounts Payable $1.70M.
- 2023-12-31: Accounts Payable $580.00K.
| Period end | Accounts Payable |
|---|---|
| 2024-09-30 | $1.70M 10-Q · filed 2024-11-12 |
| 2023-12-31 | $580.00K 10-Q · filed 2024-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B |